Saturday, August 22, 2026
ExploreSearch
Via News
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Platforms Rush to Establish Content-Authenticity Standards Amid Leadership Shakeups and Sustained Capex
Within days of each other in mid-August 2026, Google, Anthropic, and Spotify moved to formalize AI content watermarking and labeling policies, signaling an industry-wide push toward self-governed provenance standards as generative AI output floods consumer platforms. The shift coincides with executive turnover at OpenAI (Brad Lightcap's departure) and Meta's public AI manifesto, all set against continued heavy AI infrastructure capital expenditure and finance-sector moves (e.g., Wall Street paying for algorithmic edges on social signals) that underscore AI's deepening entanglement with capital markets.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts report JPMorgan Chase & Co.'s revenue for the same fiscal period (FY 2025) with the same observation date (2025-12-31), but with different values: $182.447 billion vs. $185 billion. The ~1.4% difference ($2.553 billion) is too large to be explained by rounding alone and represents conflicting data for the identical time period.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,977
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,977 facts checked against source5,242 source documents archived
Work with this data → vianewsagency.com
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· November 13, 2025

Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update

View original at globenewswire.com
Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update Closed financing of up to $50 million; initial tranche of $30 million provides runway through 2027 Hosted key opinion leader event highlighting the important role of the Aryl Hydrocarbon Receptor (AhR) in intestinal inflammation, the…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • EQ504 has potential to be a first-in-class, oral and colon-targeted therapeutic for ulcerative colitis

    80% confidence

  • Initial tranche of financing is expected to fund Company operations through 2027

    80% confidence

  • AhR modulation is a differentiated and multi-modal approach to decreasing tissue inflammation while promoting tissue repair

    80% confidence

  • Cash and cash equivalents on the balance sheet as of September 30, 2025 are capable of funding currently planned operations through 2027

    80% confidence

  • Equillium expects to be ready to initiate Phase 1 clinical study in mid-2026 with potential to achieve proof-of-concept with addition of UC patient cohorts following SAD/MAD portion

    80% confidence

  • EQ504 is a potent and selective AhR modulator that may be administered orally and is formulated to target the colon, representing a next-generation therapeutic to treat UC locally

    80% confidence

  • EQ504 has broad therapeutic potential in UC as a potential standalone oral therapy, or in combination with other therapeutic approaches

    80% confidence

  • AhR modulation is clinically validated in skin and GI diseases through VTAMA and botanical indigo naturalis

    80% confidence

Cited in these Via News reports